Fig. 1From: Prognostic significance of different molecular typing methods and immune status based on RNA sequencing in HR-positive and HER2-negative early-stage breast cancerSurvival analysis based on RS and ROR risk categories. Disease-free survival analysis by RS (a) and ROR (b); Distant metastasis-free survival analysis by RS (c) and ROR (d)Back to article page